4.6 Review

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Letter Medicine, General & Internal

High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?

M. Pineton de Chambrun et al.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Safety of intermediate dose of low molecular weight heparin in COVID-19 patients

Massimo Mattioli et al.

Summary: This study retrospectively evaluated the safety of intermediate dose regimens of low-weight molecular heparin in COVID-19 patients. The results suggest that the use of an intermediate dose of LWMH appears to be feasible and safe in COVID-19 patients, without increasing the risk of bleeding or need for blood transfusion. Further studies are needed to confirm these findings.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Letter Cardiac & Cardiovascular Systems

Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence

Julien Poissy et al.

CIRCULATION (2020)

Letter Hematology

Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2

Robert Beun et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)

Article Hematology

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Jean-Francois Llitjos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Saskia Middeldorp et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Jecko Thachil et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Songping Cui et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Cardiac & Cardiovascular Systems

Heparin resistance in COVID-19 patients in the intensive care unit

D. White et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Letter Critical Care Medicine

VTE in ICU Patients With COVID-19

Matthew Moll et al.

CHEST (2020)

Editorial Material Cardiac & Cardiovascular Systems

Hospitalized COVID-19 Patients and Venous Thromboembolism A Perfect Storm

Alex C. Spyropoulos et al.

CIRCULATION (2020)

Letter Hematology

Prevalence of venous thromboembolism in critically ill patients with COVID-19

Joseph A. Hippensteel et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Letter Medicine, General & Internal

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Seda Bilaloglu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

Julien Nahum et al.

JAMA NETWORK OPEN (2020)

Letter Cardiac & Cardiovascular Systems

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis

Chiara Kessler et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Article Hematology

Venous thromboembolism in critically III patients with COVID-19: Results of a screening study for deep vein thrombosis

Alban Longchamp et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Public, Environmental & Occupational Health

Meta-analysis of prevalence

Jan J. Barendregt et al.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2013)

Article Health Care Sciences & Services

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement

Damian Hoy et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)

Article Medicine, General & Internal

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)